Brief: Seelos Therapeutics Announces The Signing Of A Material Transfer Agreement With U.S. Army Medical Materiel Development Activity (Usammda) To Evaluate Sls-002 For Treatment Of Ptsd
24/09/2024 13:21
Sept 24 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS ANNOUNCES THE SIGNING OF A MATERIAL
TRANSFER
AGREEMENT WITH U.S. ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY
(USAMMDA) TO EVALUATE SLS-002 FOR TREATMENT OF PTSD
* SEELOS THERAPEUTICS INC - DOSING OF SLS-002 COHORT
EXPECTED TO
COMMENCE IN 4Q2024
Source text for Eikon: ID:nPn1QQx1Ma
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio